Endoscopic Sleeve Gastroplasty: A Safe Bariatric Intervention for Class III Obesity (BMI > 40).

Anuragh R GudurCalvin GengMark RadlinskiZequan YangVanessa M ShamiAndrew Y WangAlexander Podboy

Published in: Obesity surgery (2023)

The feasibility and safety of ESG in patients with class III obesity are comparable to patients with class I and II obesity. Additionally, the safety of ESG in patients with class III obesity is comparable to SG and safer than RYGB. Endoscopic sleeve gastroplasty: a safe bariatric intervention for class III obesity (BMI > 40).

Keyphrases

weight loss
insulin resistance
weight gain
metabolic syndrome
high fat diet induced
type diabetes
roux en y gastric bypass
bariatric surgery
randomized controlled trial
body mass index
gastric bypass